Inhibition of HBV replication by siRNA in a stable HBV‐producing cell line

Potent inhibition of endogenous gene expression by RNA interference has been achieved by using sequence‐specific posttranscriptional gene silencing through the action of small interfering RNA molecules (siRNA). In these reports, the natural function of genes could be deduced through the ensuing loss of function. Based on the extraordinary effectiveness in silencing endogenous genes, we wondered whether siRNA could be applied against viral replication in a hepatitis B virus (HBV) model using HBV‐specific siRNA. To test this idea, HepG2 2.2.15, a human hepatoblastoma cell line that constitutively produces infectious HBV particles, was transfected with HBV‐specific siRNAs and controls. HBV surface antigen (HBsAg) secretion into culture media was inhibited by 78%, 67%, and 42% with siRNA against the polyadenylation (PA), precore (PreC), and surface (S) regions, respectively, compared with controls as detected by enzyme‐linked immunosorbent assay. After exposure to HBVPA siRNA, Northern blot analysis showed that HBV pregenomic RNA levels were decreased by 72%, and levels of HBV RNA containing the polyadenylation signal sequence were suppressed by 86%, as detected by RNase protection assay. Levels of HBV coreassociated DNA, a replication intermediate, also decreased by 71%. Immunocytochemistry revealed that 30% to 40% of the cells transfected with HBVPA siRNA were completely negative for detectable HBsAg levels. Controls consisting of treatment with HBV‐specific siRNA alone, lipofection reagent alone, or random double‐stranded RNA (dsRNA) lipofection complex failed to decrease HBV surface antigen, HBV messenger RNA (mRNA), or core‐associated HBV‐DNA levels. In conclusion, siRNA inhibits hepatitis B viral replication in a cell culture system. Future studies are needed to explore the specific delivery of siRNA to liver cells in vivo and the applicability of this approach. (Hepatology 2003;38:842–850).

[1]  M. Shapiro,et al.  Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions , 1988, Journal of virology.

[2]  Z. Adelman,et al.  RNA Silencing of Dengue Virus Type 2 Replication in Transformed C6/36 Mosquito Cells Transcribing an Inverted-Repeat RNA Derived from the Virus Genome , 2002, Journal of Virology.

[3]  D. Tyrrell,et al.  Hepatitis C virus replication in mice with chimeric human livers , 2001, Nature Medicine.

[4]  Ki-Young Lee,et al.  Cloned zebrafish by nuclear transfer from long-term-cultured cells , 2002, Nature Biotechnology.

[5]  Anton P. McCaffrey,et al.  Inhibition of hepatitis B virus in mice by RNA interference , 2003, Nature Biotechnology.

[6]  F. Bushman,et al.  Inhibition of Retroviral Pathogenesis by RNA Interference , 2002, Current Biology.

[7]  K. Watabe,et al.  Antisense oligodeoxyribonucleotides inhibit the expression of the gene for hepatitis B virus surface antigen. , 1990, The Journal of general virology.

[8]  Anastasia Khvorova,et al.  RNA interference blocks gene expression and RNA synthesis from hepatitis C replicons propagated in human liver cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  G. Bishop,et al.  CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.

[10]  Phillip D. Zamore,et al.  RNA interference: listening to the sound of silence , 2001, Nature Structural Biology.

[11]  H. Blum,et al.  Gene therapy for chronic viral hepatitis: Ribozymes, antisense oligonucleotides, and dominant negative mutants , 1997, Hepatology.

[12]  Douglas S. Conklin,et al.  Gene expression: RNA interference in adult mice , 2002, Nature.

[13]  M. Gerber,et al.  The inhibitory effects of antisense RNA on hepatitis B virus surface antigen synthesis. , 1997, The Journal of general virology.

[14]  M. Carmell,et al.  Posttranscriptional Gene Silencing in Plants , 2006 .

[15]  H. Margolis,et al.  Strategies to prevent and control hepatitis B and C virus infections: a global perspective. , 1999, Vaccine.

[16]  Y. Cheng,et al.  Antisense oligonucleotides as therapeutic agents--is the bullet really magical? , 1993, Science.

[17]  C. Wu,et al.  Human hepatocytes transplanted into genetically immunocompetent rats are susceptible to infection by hepatitis B virus in situ , 2001, Journal of viral hepatitis.

[18]  S. Ding,et al.  Induction and Suppression of RNA Silencing by an Animal Virus , 2002, Science.

[19]  J. Lieberman,et al.  siRNA-directed inhibition of HIV-1 infection , 2002, Nature Medicine.

[20]  C. Wu,et al.  Inhibition of hepatitis B virus replication by targeted pretreatment of complexed antisense DNA in vitro , 1996, Hepatology.

[21]  J. Wands,et al.  Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication , 1991, Journal of virology.

[22]  A. Caudy,et al.  Role for a bidentate ribonuclease in the initiation step of RNA interference , 2001 .

[23]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[24]  C. Rice,et al.  Clearance of replicating hepatitis C virus replicon RNAs in cell culture by small interfering RNAs , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Wands,et al.  Antisense RNA complementary to hepatitis B virus specifically inhibits viral replication. , 1998, Gastroenterology.

[26]  Y. Liaw.  Therapy of chronic hepatitis B: current challenges and opportunities , 2002, Journal of viral hepatitis.

[27]  P. Sharp,et al.  RNAi Double-Stranded RNA Directs the ATP-Dependent Cleavage of mRNA at 21 to 23 Nucleotide Intervals , 2000, Cell.

[28]  G. Acs,et al.  Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Erickson,et al.  Evidence that processed small dsRNAs may mediate sequence-specific mRNA degradation during RNAi in Drosophila embryos , 2000, Current Biology.

[30]  S. Hammond,et al.  An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells , 2000, Nature.

[31]  F. Chisari,et al.  Interference of hepatitis C virus RNA replication by short interfering RNAs , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  C. Wu,et al.  Specific inhibition of hepatitis B viral gene expression in vitro by targeted antisense oligonucleotides. , 1992, The Journal of biological chemistry.

[33]  S. Thung,et al.  Morphologic, immunohistochemical, and ultrastructural studies of the production of hepatitis B virus in vitro. , 1988, Laboratory investigation; a journal of technical methods and pathology.

[34]  T. Tuschl,et al.  RNA interference is mediated by 21- and 22-nucleotide RNAs. , 2001, Genes & development.

[35]  R. Andino,et al.  Short interfering RNA confers intracellular antiviral immunity in human cells , 2002, Nature.

[36]  Y. Shaul,et al.  Inhibition of hepatitis B virus expression and replication by RNA interference , 2003, Hepatology.

[37]  K. Eguchi,et al.  Short interfering RNA‐directed inhibition of hepatitis B virus replication , 2003, FEBS letters.

[38]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[39]  Ali Ehsani,et al.  Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells , 2002, Nature Biotechnology.

[40]  E. Galun,et al.  The hepatitis B virus–trimera mouse: A model for human HBV infection and evaluation of anti‐HBV therapeutic agents , 1999, Hepatology.